Subscribe to RSS

DOI: 10.1055/s-0045-1809629
Minimally Invasive Punch Biopsy for Malignant Brain Tumor
Biópsia por punção minimamente invasiva para tumores cerebrais malignos
Abstract
Objective
To describe an innovative minimally invasive technique for brain lesion biopsy with low cost, high precision, and reduced surgical risk in addition to providing sufficient material for pathological analysis.
Methods
This is a consecutive series of cases of patients with intracranial expansive lesions with low resection possibility and high surgical risk. They were admitted to the Sergipe Emergency Hospital from March 2020 to November 2020. The approach point was determined using the NeuroKeypoint app.
Results
The same procedure was performed on five patients with sedation and local anesthesia. The small treatment required reduced surgical time. All five patients had a diagnosis after collecting performed with the device and did not experience any complications associated with the method. All patients were discharged the following day, maintaining their preoperative neurological condition. Of the five patients who underwent surgery, all had confirmatory results of malignant brain tumors, with 100% accuracy, confirming the diagnosis and enabling oncological therapeutic follow-up. During the 30-day follow-up, three patients received adjuvant therapy, while two died from systemic oncological complications.
Conclusion
The presented method is feasible, safe, and has acceptable diagnostic accuracy, offering an alternative for diagnosing histological malignant brain tumors through minimally invasive biopsy.
Resumo
Objetivo
Descrever uma técnica inovadora e minimamente invasiva para biópsia de lesão cerebral, com baixo custo, alta precisão, risco cirúrgico reduzido, além de fornecer material suficiente para análise anatomopatológica.
Métodos
Trata-se de uma série consecutiva de casos de pacientes com lesões expansivas intracranianas com baixa possibilidade de ressecção e alto risco cirúrgico. Eles deram entrada no Hospital de Emergência de Sergipe de março de 2020 a novembro de 2020. O ponto de abordagem foi determinado usando o aplicativo NeuroKeypoint.
Resultados
O mesmo procedimento foi realizado em cinco pacientes com sedação e anestesia local. A pequena trepanação exigiu redução do tempo cirúrgico. Todos os cinco pacientes apresentaram resposta positiva ao procedimento e não apresentaram complicações associadas ao método. Todos os pacientes receberam alta hospitalar no dia seguinte, mantendo o quadro neurológico pré-operatório. Dos cinco pacientes operados, todos apresentaram resultados confirmatórios de tumores cerebrais malignos, com 100% de acurácia, confirmando o diagnóstico e possibilitando o acompanhamento terapêutico oncológico. Durante os 30 dias de seguimento, três pacientes receberam terapia adjuvante, enquanto dois morreram por complicações oncológicas sistêmicas.
Conclusão
O método apresentado é factível, seguro e de acurácia diagnóstica aceitável, oferecendo uma alternativa para o diagnóstico histológico de tumores cerebrais malignos por meio de biópsia minimamente invasiva.
Palavras-chave
neoplasias encefálicas - biópsia - tecnologia de baixo custo - tecnologia culturalmente apropriadaPublication History
Received: 15 August 2023
Accepted: 20 March 2025
Article published online:
16 July 2025
© 2025. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
-
References
- 1 Tsermoulas G, Mukerji N, Borah AJ, Mitchell P, Ross N. Factors affecting diagnostic yield in needle biopsy for brain lesions. Br J Neurosurg 2013; 27 (02) 207-211
- 2 Lee T, Kenny BG, Hitchock ER. et al. Supratentorial masses: stereotactic or freehand biopsy?. Br J Neurosurg 1991; 5 (04) 331-338
- 3 Hall WA. The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer 1998; 82 (09) 1749-1755
- 4 Krieger MD, Chandrasoma PT, Zee C-S, Apuzzo MLJ. Role of stereotactic biopsy in the diagnosis and management of brain tumors. Semin Surg Oncol 1998; 14 (01) 13-25
- 5 Mizobuchi Y, Nakajima K, Fujihara T. et al. The risk of hemorrhage in stereotactic biopsy for brain tumors. J Med Invest 2019; 66 (3.4): 314-318
- 6 Bander ED, Jones SH, Pisapia D. et al. Tubular brain tumor biopsy improves diagnostic yield for subcortical lesions. J Neurooncol 2019; 141 (01) 121-129
- 7 Reithmeier T, Lopez WO, Doostkam S. et al. Intraindividual comparison of histopathological diagnosis obtained by stereotactic serial biopsy to open surgical resection specimen in patients with intracranial tumours. Clin Neurol Neurosurg 2013; 115 (10) 1955-1960
- 8 McGirt MJ, Woodworth GF, Coon AL. et al. Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases. J Neurosurg 2005; 102 (05) 897-901
- 9 Organisation mondiale de la santé, Centre international de recherche sur le cancer, editors. Central nervous system tumours. 5th ed. Lyon: International agency for research on cancer; 2021.
- 10 Zuber TJ. Punch biopsy of the skin. Am Fam Physician 2002; 65 (06) 1155-1158 , 1161–1162, 1164
- 11 Fernandes de Oliveira Santos B, de Araujo Paz D, Fernandes VM. et al. Minimally invasive supratentorial neurosurgical approaches guided by Smartphone app and compass. Sci Rep 2021; 11 (01) 6778
- 12 Spiegel EA, Wycis HT, Marks M, Lee AJ. Stereotaxic Apparatus for Operations on the Human Brain. Science 1947; 106 (2754): 349-350
- 13 Henderson JM, Holloway KL, Gaede SE, Rosenow JM. The application accuracy of a skull-mounted trajectory guide system for image-guided functional neurosurgery. Comput Aided Surg 2004; 9 (04) 155-160
- 14 Woodworth G, McGirt MJ, Samdani A, Garonzik I, Olivi A, Weingart JD. Accuracy of frameless and frame-based image-guided stereotactic brain biopsy in the diagnosis of glioma: comparison of biopsy and open resection specimen. Neurol Res 2005; 27 (04) 358-362 . Doi: X40057
- 15 Henderson JM. Frameless localization for functional neurosurgical procedures: a preliminary accuracy study. Stereotact Funct Neurosurg 2004; 82 (04) 135-141
- 16 Germano IM, Queenan JV. Clinical experience with intracranial brain needle biopsy using frameless surgical navigation. Comput Aided Surg 1998; 3 (01) 33-39
- 17 Quiñones-Hinojosa A, Ware ML, Sanai N, McDermott MW. Assessment of image guided accuracy in a skull model: comparison of frameless stereotaxy techniques vs. frame-based localization. J Neurooncol 2006; 76 (01) 65-70
- 18 Benardete EA, Leonard MA, Weiner HL. Comparison of frameless stereotactic systems: accuracy, precision, and applications. Neurosurgery 2001; 49 (06) 1409-1415 , discussion 1415–1416
- 19 Riche M, Amelot A, Peyre M, Capelle L, Carpentier A, Mathon B. Complications after frame-based stereotactic brain biopsy: a systematic review. Neurosurg Rev 2021; 44 (01) 301-307
- 20 Chen C-C, Hsu P-W, Erich Wu T-W. et al. Stereotactic brain biopsy: Single center retrospective analysis of complications. Clin Neurol Neurosurg 2009; 111 (10) 835-839
- 21 Bernstein M, Parrent AG. Complications of CT-guided stereotactic biopsy of intra-axial brain lesions. J Neurosurg 1994; 81 (02) 165-168
- 22 Woodworth GF, McGirt MJ, Samdani A, Garonzik I, Olivi A, Weingart JD. Frameless image-guided stereotactic brain biopsy procedure: diagnostic yield, surgical morbidity, and comparison with the frame-based technique. J Neurosurg 2006; 104 (02) 233-237
- 23 Kickingereder P, Willeit P, Simon T, Ruge MI. Diagnostic value and safety of stereotactic biopsy for brainstem tumors: a systematic review and meta-analysis of 1480 cases. Neurosurgery 2013; 72 (06) 873-881 , discussion 882, quiz 882
- 24 Kreth FW, Muacevic A, Medele R, Bise K, Meyer T, Reulen H-J. The risk of haemorrhage after image guided stereotactic biopsy of intra-axial brain tumours–a prospective study. Acta Neurochir (Wien) 2001; 143 (06) 539-545 , discussion 545–546
- 25 Grossman R, Sadetzki S, Spiegelmann R, Ram Z. Haemorrhagic complications and the incidence of asymptomatic bleeding associated with stereotactic brain biopsies. Acta Neurochir (Wien) 2005; 147 (06) 627-631 , discussion 631
- 26 Kellermann SG, Hamisch CA, Rueß D. et al. Stereotactic biopsy in elderly patients: risk assessment and impact on treatment decision. J Neurooncol 2017; 134 (02) 303-307
- 27 Lara-Almunia M, Hernandez-Vicente J. Symptomatic intracranial hemorrhages and frame-based stereotactic brain biopsy. Surg Neurol Int 2020; 11: 218
- 28 Shakal AA, Mokbel EA. Hemorrhage after stereotactic biopsy from intra-axial brain lesions: incidence and avoidance. J Neurol Surg A Cent Eur Neurosurg 2014; 75 (03) 177-182
- 29 Roth J, Avneri I, Nimrod A, Kanner AA. Stereotactic biopsy complicated by pneumocephalus and acute pulmonary edema. Surg Neurol 2007; 68 (05) 573-576 , discussion 576
- 30 Karlsson B, Ericson K, Kihlström L, Grane P. Tumor seeding following stereotactic biopsy of brain metastases. Report of two cases. J Neurosurg 1997; 87 (02) 327-330
- 31 Quick-Weller J, Lescher S, Bruder M. et al. Stereotactic biopsy of brainstem lesions: 21 years experiences of a single center. J Neurooncol 2016; 129 (02) 243-250
- 32 Nishihara M, Sasayama T, Kudo H, Kohmura E. Morbidity of stereotactic biopsy for intracranial lesions. Kobe J Med Sci 2011; 56 (04) E148-E153
- 33 He X, Liu M, Liu C. et al. Real-time MR-guided brain biopsy using 1.0-T open MRI scanner. Eur Radiol 2019; 29 (01) 85-92
- 34 Marcus HJ, Vakharia VN, Ourselin S, Duncan J, Tisdall M, Aquilina K. Robot-assisted stereotactic brain biopsy: systematic review and bibliometric analysis. Childs Nerv Syst 2018; 34 (07) 1299-1309
- 35 Di Lorenzo N, Esposito V, Lunardi P, Delfini R, Fortuna A, Cantore G. A comparison of computerized tomography-guided stereotactic and ultrasound-guided techniques for brain biopsy. J Neurosurg 1991; 75 (05) 763-765
- 36 Lunardi P, Acqui M, Maleci A, Di Lorenzo N, Fortuna A. Ultrasound-guided brain biopsy: a personal experience with emphasis on its indication. Surg Neurol 1993; 39 (02) 148-151
- 37 Esposito F, Cappabianca P. Neuroendoscopy: general aspects and principles. World Neurosurg 2013; 79 (2, Suppl) 14.e7-14.e9
- 38 Price R. The advantages of frameless stereotactic biopsy over frame-based biopsy. Br J Neurosurg 2003; 17 (01) 90-91 , author reply 91
- 39 Giannetti AV, Alvarenga AYH, de Lima TOL, Pedrosa HA-SR, Souweidane MM. Neuroendoscopic biopsy of brain lesions: accuracy and complications. J Neurosurg 2015; 122 (01) 34-39
- 40 Almubarak AO, Alobaid A, Qoqandi O, Bafaquh M. Minimally Invasive Brain Port Approach for Accessing Deep-Seated Lesions Using Simple Syringe. World Neurosurg 2018; 117: 54-61
- 41 Chen Y-N, Omay SB, Shetty SR. et al. Transtubular excisional biopsy as a rescue for a non-diagnostic stereotactic needle biopsy-case report and literature review. Acta Neurochir (Wien) 2017; 159 (09) 1589-1595
- 42 Ratre S, Yadav YR, Parihar VS, Kher Y. Microendoscopic Removal of Deep-Seated Brain Tumors Using Tubular Retraction System. J Neurol Surg A Cent Eur Neurosurg 2016; 77 (04) 312-320
- 43 Weise LM, Bruder M, Eibach S. et al. Efficacy and safety of local versus general anesthesia in stereotactic biopsies: a matched-pairs cohort study. J Neurosurg Anesthesiol 2013; 25 (02) 148-153
- 44 Kunz M, Thon N, Eigenbrod S. et al. Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas. Neuro-oncol 2011; 13 (03) 307-316
- 45 Moriuchi S, Yamada K, Dehara M. et al. Use of 5-aminolevulinic acid for the confirmation of deep-seated brain tumors during stereotactic biopsy. Report of 2 cases. J Neurosurg 2011; 115 (02) 278-280
- 46 Marbacher S, Klinger E, Schwyzer L. et al. Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases. Neurosurg Focus 2014; 36 (02) E10
- 47 Perkins A, Liu G. Primary Brain Tumors in Adults: Diagnosis and Treatment. Am Fam Physician 2016; 93 (03) 211-217
- 48 Climans SA, Ramos RC, Laperriere N, Bernstein M, Mason WP. Outcomes of presumed malignant glioma treated without pathological confirmation: a retrospective, single-center analysis. Neurooncol Pract 2020; 7 (04) 446-452
- 49 Vaquero J, Martínez R, Manrique M. Stereotactic biopsy for brain tumors: is it always necessary?. Surg Neurol 2000; 53 (05) 432-437 , discussion 437–438
- 50 Lapa Jda S, Rangel B, Jesus A. et al. Neuroschistosomiasis Mimicking High Grade Glioma. Journal of Neurology, Psychiatry and Brain Research 2019; 04: 1-3
- 51 Matsuo K, Yamada K, Nakajima K, Nakagawa M. Neuro-Behçet disease mimicking brain tumor. AJNR Am J Neuroradiol 2005; 26 (03) 650-653
- 52 Salvarani C, Brown Jr RD, Christianson TJH. et al. Primary central nervous system vasculitis mimicking brain tumor: Comprehensive analysis of 13 cases from a single institutional cohort of 191 cases. J Autoimmun 2019; 97: 22-28
- 53 Muccio CF, Di Blasi A, Esposito G, Brunese L, D'Arco F, Caranci F. Perfusion and spectroscopy magnetic resonance imaging in a case of lymphocytic vasculitis mimicking brain tumor. Pol J Radiol 2013; 78 (03) 66-69
- 54 Krajewski KL, Hernández-Durán S, Matschke J, Abboud T. Wounded glioma with fatal outcome: A report on biopsy of anaplastic glioma in two patients. Interdiscip Neurosurg 2020; 19: 100554
- 55 Chrastina J, Novák Z, Ráha I, Slaná B, Jancálek R. [Distant wounded glioma syndrome following stereotactic biopsy–a case review]. Rozhl Chir 2011; 90 (03) 148-151